"The revenue we expect from Absorica will be greater than the revenue from our existing two products," Andrews said.
Cipher earned C$1.4 million ($1.37 million) revenue from Lipofen, a drug used to manage cholesterol, in the first quarter. Revenue from ConZipa, used to treat chronic pain in adults, was about C$300,000 in the period.
Shares of Ranbaxy Laboratories, which is valued at $4 billion, closed down 0.9 percent at 525.20 Indian rupees in a firm Mumbai market.
- Link this
- Share this
- Digg this
- Email
- Reprints
0 comments:
Post a Comment